スポンサーリンク

Department Of Hematology And Oncology Hiroshima University | 論文

Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality

スポンサーリンク